INOVATYON

Trial Description: 
Phase III international, randomized study of Trabectedin plus Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin plus PLD in patients with ovarian cancer progressing within 6-12 months of last platinum
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Recurrent Ovarian
Trial Status: 
Closed to Recruitment
Contact person: